製品の概要

製品の詳細

  • 由来Synthetic
  • アミノ酸配列
    • 生物種Human
    • 配列C-DGEKANKDA EQKED
    • 領域352 to 365

関連製品

特性

Our Abpromise guarantee covers the use of ab45880 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Blocking - Blocking peptide for Anti-DCDC2 antibody (ab45868)

  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.

関連情報

  • 別名
    • DCDC 2
    • DCDC2
    • DCDC2_HUMAN
    • DCDC2A
    • Doublecortin domain containing 2
    • doublecortin domain containing protein 2
    • Doublecortin domain-containing protein 2
    • HGNC:18141
    • KIAA1154
    • Protein RU2S
    • RU 2
    • RU2
    • RU2S
    • RU2S protein
    see all
  • 機能May be involved in neuronal migration during development of the cerebral neocortex.
  • 組織特異性Ubiquitously expressed. In brain, highly expressed in the entorhinal cortex, inferior temporal cortex, medial temporal cortex, hypothalamus, amygdala and hippocampus.
  • 関連疾患Defects in DCDC2 may be a cause of susceptibility to dyslexia type 2 (DYX2) [MIM:600202]; also known as specific reading disability type 2. Dyslexia is a relatively common, complex cognitive disorder that affects 5% to 10% of school-aged children. The disorder is characterized by an impairment of reading performance despite adequate motivational, educational and intellectual opportunities and in the absence of sensory or neurological disability.
  • 配列類似性Contains 2 doublecortin domains.
  • Information by UniProt

DCDC2 peptide (352-365) (ab45880) 使用論文

ab45880 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab45880.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"